268 related articles for article (PubMed ID: 15700330)
1. Detection and characterisation of liver metastases.
Albrecht T; Hohmann J; Oldenburg A; Skrok J; Wolf KJ
Eur Radiol; 2004 Oct; 14 Suppl 8():P25-33. PubMed ID: 15700330
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
[TBL] [Abstract][Full Text] [Related]
3. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
4. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
5. Detection of hepatic metastases with low MI real time contrast enhanced sonography and SonoVue.
Oldenburg A; Hohmann J; Foert E; Skrok J; Hoffmann CW; Frericks B; Wolf KJ; Albrecht T
Ultraschall Med; 2005 Aug; 26(4):277-84. PubMed ID: 16123921
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of contrast-enhanced ultrasound in focal lesions of the liver using cadence contrast pulse sequencing.
Bleuzen A; Huang C; Olar M; Tchuenbou J; Tranquart F
Ultraschall Med; 2006 Feb; 27(1):40-8. PubMed ID: 16470478
[TBL] [Abstract][Full Text] [Related]
7. Comparison of diagnostic performance of unenhanced vs SonoVue - enhanced ultrasonography in focal liver lesions characterization. The experience of three Italian centers.
Quaia E; Stacul F; Gaiani S; Ricci P; Passariello R; Curzio D; Pozzi Mucelli R
Radiol Med; 2004; 108(1-2):71-81. PubMed ID: 15269691
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients.
von Herbay A; Westendorff J; Gregor M
J Clin Ultrasound; 2010 Jan; 38(1):1-9. PubMed ID: 19790253
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents.
Hohmann J; Albrecht T; Hoffmann CW; Wolf KJ
Eur J Radiol; 2003 May; 46(2):147-59. PubMed ID: 12714231
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of focal liver lesions with unenhanced and contrast enhanced low MI real time ultrasound: on-site unblinded versus off-site blinded reading.
Hohmann J; Skrok J; Basilico R; Jennett M; Müller A; Wolf KJ; Albrecht T
Eur J Radiol; 2012 Mar; 81(3):e317-24. PubMed ID: 22100374
[TBL] [Abstract][Full Text] [Related]
11. Real-time imaging with the sonographic contrast agent SonoVue: differentiation between benign and malignant hepatic lesions.
von Herbay A; Vogt C; Willers R; Häussinger D
J Ultrasound Med; 2004 Dec; 23(12):1557-68. PubMed ID: 15557299
[TBL] [Abstract][Full Text] [Related]
12. Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors.
Rennert J; Georgieva M; Schreyer AG; Jung W; Ross C; Stroszczynski C; Jung EM
Clin Hemorheol Microcirc; 2011; 49(1-4):67-81. PubMed ID: 22214679
[TBL] [Abstract][Full Text] [Related]
13. [Real-time contrast-enhanced ultrasound in the evaluation of focal liver lesions: diagnostic efficacy and economical issues from a French multicentric study].
Tranquart F; Correas JM; Ladam Marcus V; Manzoni P; Vilgrain V; Aube C; Elmaleh A; Chami L; Claudon M; Cuilleron M; Diris B; Garibaldi F; Lucidarme O; Marion D; Beziat C; Rode A; Tasu JP; Trillaud H; Bleuzen A; Le Gouge A; Giraudeau B; Rusch E
J Radiol; 2009 Jan; 90(1 Pt 2):109-22. PubMed ID: 19212279
[TBL] [Abstract][Full Text] [Related]
14. [Baseline and contrast-enhanced ultrasound of the liver in tumor patients].
Oldenburg A; Albrecht T
Ultraschall Med; 2008 Oct; 29(5):488-98. PubMed ID: 19241505
[TBL] [Abstract][Full Text] [Related]
15. Focal liver lesions: can SonoVue-enhanced ultrasound be used to differentiate malignant from benign lesions?
Dai Y; Chen MH; Yin SS; Yan K; Fan ZH; Wu W; Wang YB; Yang W
Invest Radiol; 2007 Aug; 42(8):596-603. PubMed ID: 17620943
[TBL] [Abstract][Full Text] [Related]
16. Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI.
Trillaud H; Bruel JM; Valette PJ; Vilgrain V; Schmutz G; Oyen R; Jakubowski W; Danes J; Valek V; Greis C
World J Gastroenterol; 2009 Aug; 15(30):3748-56. PubMed ID: 19673015
[TBL] [Abstract][Full Text] [Related]
17. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.
Seitz K; Strobel D
Ultraschall Med; 2016 Jun; 37(3):229-32. PubMed ID: 27276056
[TBL] [Abstract][Full Text] [Related]
18. [Value of contrast-enhanced ultrasound in the diagnosis of hepatocarcinoma in focal lesions detected in patients with liver disease].
Gómez Rodríguez RA; Artaza Varasa T; González de Frutos C; Sánchez Ruano JJ; Repiso Ortega A; Pérez-Grueso Macías MJ; Muñoz Rosas C; Carrobles Jiménez JM
Gastroenterol Hepatol; 2007; 30(7):381-6. PubMed ID: 17692194
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of contrast-enhanced ultrasound in differentiating benign and malignant focal liver lesions: a retrospective study.
Ooi CC; Low SC; Schneider-Kolsky M; Lombardo P; Lim SY; Abu Bakar R; Lo RH
J Med Imaging Radiat Oncol; 2010 Oct; 54(5):421-30. PubMed ID: 20958940
[TBL] [Abstract][Full Text] [Related]
20. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
